Introduction: Peripheral nerve tumors, including neuromas, schwannomas, and neurofibromas, are neoplasms that affect the peripheral nerve network. These tumors often cause pain, motor and sensory function loss, in some cases, risk of malignant transformation. Microsurgical removal is the preferred treatment for tumors causing significant compression or severe symptoms, as it helps preserve nerve function by minimizing damage to surrounding structures. In Brazil, these procedures are conducted within the Unified Health System (SUS) and primarily funded by the Strategic Actions and Compensations Fund (FAEC) and the Medium and High Complexity Fund (MAC), covering both hospital and professional expenses. Given the high costs associated with microsurgical treatment of peripheral nerve tumors, analyzing total costs and funding sources is essential to optimize resource allocation and ensure financial sustainability in high-complexity treatments.
Methods: Data for this study were sourced from the SUS Hospital Information System (SIH/SUS), covering January 2008 to August 2024. The analysis included approved Hospitalization Authorizations (AIHs), admissions, total costs for hospital and professional services, and funding sources, specifically FAEC and MAC.
Results: Over the study period, 5,330 hospital admissions for microsurgical treatment of peripheral nerve tumors were recorded, totaling R$ 2,767,373.50. Hospital services accounted for R$ 1,888,608.69, including federal supplements of R$ 12,229.56. Professional services amounted to R$ 858,766.10, with additional support of R$ 7,056.00. The average cost per AIH was R$ 519.21. FAEC funded 58 procedures, while MAC covered 5,272 admissions.
Conclusion : These procedures are primarily funded by MAC, underscoring SUS’s central role in providing high-complexity care. Findings highlight the importance of cost and outcome monitoring to ensure continuity and efficiency in high-complexity treatments. This monitoring benefits patients and promotes effective use of public resources, supporting the health system's ability to manage complex cases effectively.